Proteinase B disruption is required for high level production of human mechano-growth factor in Saccharomyces cerevisiae.
Morozkina. Elena V EV; Marchenko. Alexey N AN; Keruchenko. Jan S JS; Keruchenko. Irina D ID; Khotchenkov. Vyacheslav P VP; Popov. Vladimir O VO; Benevolensky. Sergei V SV
Key Findings
- s proteinase B.",
- ,
Practical Outcomes
- For DIY peptide makers, engineering a PRB1‑knockout yeast strain can dramatically improve MGF production yields, making small‑scale synthesis more feasible. The reported yield (~50 mg/L) may be enough for experimental dosing, but users still need to purify the peptide and confirm activity before any human use.
Summary
Scientists figured out how to make the muscle‑repair peptide MGF in baker's yeast. They discovered that a yeast enzyme called proteinase B chews the peptide up, so they deleted the gene for that enzyme. This boosted the amount of usable MGF about five times, up to roughly 50 mg per litre, and the product was shown to make human muscle cells grow in a lab test.
Abstract
Mechano-growth factor (MGF) is a product of a unique muscle-specific splice variant of the insulin-like growth factor I gene. Potential use of MGF to improve regenerative capability of skeletal muscle as well as to prevent neuronal damage has been widely discussed. Human MGF was expressed in Saccharomyces cerevisiae, but the yield of the recombinant protein was low due to its rapid degradation. The proteinase B was identified as the enzyme responsible for MGF processing. A yeast strain with Deltaprb1 deletion was created resulting in a fivefold increase of MGF yield that reached 50 mg/l. The biological activity of recombinant MGF was verified in a proliferation assay employing human postnatal myoblasts.
Study Information
pubmed
2010
2010-06-08T00:00:00.000Z
10.1159/000315460
6
29